Research Article | Open Access
Berberine Inhibits Intestinal Polyps Growth in Apc (min/+) Mice via Regulation of Macrophage Polarization
Antitumor effect of berberine has been reported in a wide spectrum of cancer, however, the mechanisms of which are not fully understood. The aim of this study was to investigate the hypothesis that berberine suppresses tumorigenesis in the familial adenomatous polyposis (FAP) by regulating the macrophage polarization in Apc (min/+) mouse model. Berberine was given to Apc (min/+) mice for 12 weeks. Primary macrophages were isolated; after berberine treatment, the change in signaling cascade was determined. The total number and size of polyps were reduced remarkably in berberine group, compared with control group. A significant decrease in protein levels of F4/80, mannose receptor (MR), and COX-2 in stroma of intestinal polyps and an increase in the level of iNOS were observed after berberine treatment. The mRNA level of MR and Arg-1 in berberine group was significantly lower than those in IL-10 or IL-4 group, while no significant difference in mRNA levels of iNOS and CXCL10 was observed. The migration and invasiveness assays in vitro showed that berberine could reduce the capability of migration and invasiveness. These findings suggest that berberine attenuates intestinal tumorigenesis by inhibiting the migration and invasion of colorectal tumor cells via regulation of macrophage polarization.
Familial adenomatous polyposis (FAP), which is diagnosed by detection of adenomatous polyps, is a hereditary tumorous predisposition syndrome; it is caused by germline mutation, especially in the adenomatous polyposis coli (APC) genes . In patients with FAP, huge amount of polyps appears in the colorectal area during second and third decades. It is reported that APC gene mutation leads to FAP and further results in the development of multiple colorectal adenomas at an early age, which finally causes CRC [2, 3].
Berberine is an alkaloid isolated from Coptis chinensis, which is commonly used in Chinese traditional medicine to treat gastrointestinal disorders . Recently, berberine is demonstrated to have multiple pharmacological activities, including anticancer effect [5–7]. Our previous work demonstrated that berberine could inhibit the proliferation of colorectal cancer cells by inhibiting wnt/β-catenin activity, where nuclear translocation of β-catenin was disrupted . Additionally, anti-inflammatory effect of berberine was documented in several disease models, such as diabetes [9, 10]. However, the anti-inflammatory effect of berberine on intestinal tumor is poorly understood.
In this study, we investigated the effect of berberine on macrophage polarization in the development of FAP. The Apc (min/+) mice model, a well established spontaneous intestinal tumorigenesis mouse model, was applied. The findings suggested that berberine suppresses tumorigenesis in the familial adenomatous polyposis (FAP) by regulating the macrophage polarization.
2. Materials and Methods
2.1. Establishment of Animal Model
Five four-week-old Apc (min/+) mice and five age-matched C57BL/6 mice were purchased from Model Animal Research Center of Nanjing University. As described previously , berberine was given by drinking water (0.1% w/v) daily for up to 12 weeks. All animals were maintained on a 12-hour light/dark cycle and were fed ad libitum. The small intestine and colon were taken from mice under anesthesia for further study. The present study was performed with the approval of the Committee for Animal Research at Tianjin Medical University.
2.2. Cell Culture
Mouse peritoneal macrophages (MPM) were isolated from wild-type C57BL/6 mice as described previously , with minor modifications. MPM, mouse macrophage-like cells RAW264.7, and HT-29 cells purchased from ATCC were plated and cultured in DMEM with 10% FBS at 37°C with 5% CO2. In some experiments, MPM were treated with 20 ng/mL IL-4 or IL-10 with/without berberine or 20 ng/mL INF-γ. RAW264.7 cells were replated on a 0.4 μm insert for noncontacting coculture with HT-29.
2.3. Real-Time PCR Analysis
Expression levels of mRNAs were evaluated by real-time PCR as previously described , with slight modification. Total RNA was isolated with TRIzol reagent (Invitrogen, USA). Real-time PCR was performed on a GeneAmp 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) with SYBR® Premix Ex Taq™ kit (TaKaRa). The primers sequences were listed in Table 1.
2.4. Western Blot Analysis
Western blotting was performed on SDS-PAGE Electrophoresis System as described previously . Briefly, 30 μg protein of each sample was resuspended in a reduced sample buffer and then was electrophoresed on a 10% Tris gel with running buffer; then it was blotted to PVDF membrane. Membranes were blocked with 5% nonfat milk and incubated overnight with an anti-COX-2 antibody (Abcam) or with anti-β-actin antibody (Sigma). Immunoreactive bands were detected with ECL-Plus (GE Healthcare) following incubation with secondary antibodies. The band intensity was quantified densitometrically using ImageJ software.
Tissues isolated from mice under anesthesia were fixed with 4% PFA overnight; they were washed three times with PBS. After being embedded in paraffin, tissues were sectioned into 5 μm slices and were stained with anti-COX-2, anti-iNOS, anti-MR, and anti-F4/80 antibodies overnight at 4°C. The following steps were then performed with the immunostaining kit according to the manufacturer’s instructions.
2.6. Cell Proliferation
MTT (Sigma, USA) were purchased commercially. The cell proliferation was determined according to manufacturer’s instruction.
2.7. Cell Migration Assay
The migration of HT-29 cells was detected using 24-well Transwell inserts (Corning, USA) coated with 30 μg of Matrigel (BD Biosciences), as described previously . Briefly, berberine-pretreated RAW264.7 cells were seeded into 24-well culture plates at a density of 1 × 105 cells per well. In addition, 1 × 104 HT-29 cells were seeded in the upper chamber, the upper surface of which was coated with a thin layer of Matrigel (5 mg/mL). After incubation for 24 h, the membranes were removed and were stained with hematoxylin and eosin (H&E), and the numbers of cells that invaded into Matrigel were counted in three randomly selected fields under light microscopy.
Scratch wound assays were applied to HT-29 cells as described . Briefly, HT-29 cells were seeded at a density of 5 × 105 cells into 6-well-plate. A linear mechanical scratch wound was generated using a 20 μL plastic pipette tip, after noncontacting coculture with berberine-pretreated RAW264.7. The cells were exposed to 20 μM or 40 μM berberine for 12 h or 24 h. Phase contrast images were taken at 0 h, 12 h, and 24 h after scratching.
2.8. Statistical Analyses
The in vitro tests were performed three times independently in triplicate. Data were expressed as the means ± SEM and were subjected to one-way ANOVA. For multiple datasets, a post hoc multiple comparison (two-tailed multiple -test with Bonferroni correction) was applied.
3.1. Berberine Treatment Leads to Alteration in the Proportion and Distribution of the Macrophages in the Intestinal Polyps
Macrophages play an important role in invasion, proliferation, and metastasis of tumor cells. Previously, we reported that berberine could attenuate intestinal tumor development in Apc (min/+)  (Figure 1(a)). Then, the effect of berberine on macrophages number in the intestinal villi was identified by F4/80, iNOS, and MR immunohistochemistry in the small intestine. Compared with control group, the number of F4/80+ and MR+ macrophages was significantly decreased in the small intestine of berberine group, while the number of iNOS+ macrophages was increased significantly (Figure 1(b)). Accordingly, an elevation in mRNA level of iNOS together with a decrease in MR level was observed in berberine group, compared with control group (Figure 1(c)). Simultaneously, immunohistochemical double-staining results showed that the majority of the iNOS and MR expressions were colocalized in F4/80+ cells (Figure 1(d)).
3.2. Berberine Reduces Inflammation Level in the Intestinal Polyps
The anti-inflammatory effect of berberine on the development of intestinal polyps was investigated afterward by determining the protein level of COX-2. Immunohistochemistry result showed that significant reduction of COX-2 positive cells was observed after berberine treatment (Figures 2(a) and 2(b)), whereas a decrease in COX-2 protein level was confirmed in berberine group as well (Figure 2(c)).
3.3. Berberine Induces M2 to M1 Phenotype Switching
To verify whether berberine affects macrophage polarization, real-time PCR was performed to detect mRNA level of IL-12, a marker of M2 macrophage, and IFN-γ, a marker of M1 macrophage. After berberine treatment, IL-12 mRNA level was decreased, while IFN-γ was elevated significantly in the intestinal polyps (Figure 3(a)).
To further confirm the effect of berberine on macrophage polarization, we isolated MPM and then induced these cells into M2 macrophage by IL-4 or IL-10. No change in iNOS and CXCL10 mRNA level was observed. In contrast, mRNA levels of MR and Arg-1 were significantly suppressed, which was induced by IL-4 or IL-10 (Figures 3(b) and 3(c)).
3.4. Berberine Suppresses Invasion and Migration of Tumor Cells via Alteration in Macrophage Polarization
To investigate whether berberine affects invasion and migration of tumor cells, noncontacting coculture of HT-29 cells and RAW264.7 was conducted, in which M2 polarization was induced by berberine. Firstly, we performed scratch assay to assess the effect of berberine-induced M2 macrophage on HT-29 cells migration. HT-29 cells migration, which was confirmed after being cocultured with IL-4 induced M2 macrophage, was suppressed when M2 macrophage was treated with berberine (Figure 4(a)). Then, Transwell migration assay was performed to verify the effect of berberine on tumor cell migration. A remarkable decrease of cell migration was demonstrated in berberine treated M2 macrophage group in a dose-dependent manner (Figure 4(b)).
3.5. Berberine Treatment Could Reduce NADPH Oxidase (NOX) mRNA Level in Macrophages
Since reactive oxygen species (ROS) could specifically affect the polarization of M2 macrophage, we measured mRNA expression levels of NOX2 and NOX4 in the M2 macrophage. After berberine treatment, mRNA level of NOX2 was significantly reduced, whereas no change in mRNA level of NOX4 was observed (Figure 5).
Chinese herbal medicine is an important part of alternative medicine. Berberine is a bioactive component originated from Coptidis Rhizome; it has been widely used as immunomodulatory agent for treating autoimmune disease including inflammatory bowel disease and ulcerative colitis, as well as colorectal cancer [15–17]. In this study, antitumor effect of berberine was demonstrated in Apc (min/+) mice model, which was in accordance with our previous study. In the intestinal polyps of Apc (min/+), macrophage infiltration was reduced after berberine treatment, accompanied by a decreased M2 polarization. In vitro study demonstrated that invasion and migration of tumor cells were significantly decreased when they were cocultured with berberine treated macrophages. Interestingly, expression of NOX2 in M2 macrophage was suppressed by berberine, whereas expression of NOX4 was not affected. These findings indicated that berberine exhibited antitumor effects possibly by reducing expression of NOX2, which further affected polarization of macrophages.
Macrophages play an important role in invasion into normal tissues, proliferation and survival, and metastasis of tumor cells . Previously, COX-2 inhibition was reported to cause the loss of the M2 macrophages phenotype, which may assist prevention of cancer metastasis . Our results showed that a switch from M2 to M1 phenotype was induced by berberine, and COX-2 expression was decreased, accordingly. These data suggested that berberine may cause macrophages polarization via regulating the COX-2 pathway during the inflammation.
NADPH Oxidase, a major source of reactive oxygen species (ROS) produced in response to stimuli, was an important factor involved in M1 macrophage differentiation [20–22]. It was reported that NOX2 and/or NOX4 derived ROS would be suppressed by berberine in the macrophages [23, 24], where anti-inflammatory effect of berberine was demonstrated. In this study, we observed that mRNA level of NOX2, but not NOX4, was reduced by berberine, in accordance with macrophage differentiation. In addition, COX-2 expression was reported to be regulated by NADPH Oxidase/ROS pathway in different cell types [25, 26], which indicated that M2 to M1 phenotype switch induced by berberine would be regulated through the mechanism of NADPH Oxidase/ROS/COX-2 signaling pathway. Further investigation is needed to clarify how berberine regulates the expression level of NADPH Oxidase.
In conclusion, berberine suppressed intestinal tumorigenesis in the Apc (min/+) mice model. This antitumor effect of berberine is possibly mediated by a reduction in M2 macrophage polarization via NADPH Oxidase/ROS/COX-2 signaling pathway.
The authors declare that there is no potential conflict of interests.
Meiyu Piao and Hailong Cao contributed equally to this work; Hailong Cao, Fang Yan, and Bangmao Wang designed the research; Fang Yan and Bangmao Wang provided the guidance for the experiment; Meiyu Piao and NaNa He completed animal experiments and collected specimens; Meiyu Piao, NaNa He, and Boli Yang performed immunohistochemistry and immunofluorescence test; Meiyu Piao and Mengque Xu cultured cells and carried out PCR and Western blot experiment; Meiyu Piao, Hailong Cao, and Wenxiao Dong performed the experiments Transwell migration assay; Meiyu Piao, Boli Yang, and Hailong Cao analyzed the data and carried out statistical analysis; and Meiyu Piao, Hailong Cao, and Bing Zhou wrote the paper.
The study was supported by National Natural Science Foundation of China (nos. 81300272, 81570478, and 81470796); Tianjin Binhai Science and Technology Project of Health Bureau (no. 2013BWKL003); and Medjaden Academy & Research Foundation for Young Scientists (no. MJR20150023).
- E. Half, D. Bercovich, and P. Rozen, “Familial adenomatous polyposis,” Orphanet Journal of Rare Diseases, vol. 4, no. 1, article 22, 2009.
- J. Groden, A. Thliveris, W. Samowitz et al., “Identification and characterization of the familial adenomatous polyposis coli gene,” Cell, vol. 66, no. 3, pp. 589–600, 1991.
- B. Eser and M. Yıldar, “Two different nucleotide substitutions of APC gene in a family with familial adenomatous polyposis,” Journal of Surgical Case Reports, vol. 2015, no. 9, Article ID rjv118, 2015.
- X.-P. Wang, F. Lei, F. Du et al., “Protection of gastrointestinal mucosa from acute heavy alcohol consumption: the effect of berberine and its correlation with TLR2, 4/IL1β-TNFα signaling,” PLoS ONE, vol. 10, no. 7, Article ID e0134044, 2015.
- J. Yao, W. Kong, and J. Jiang, “Learning from berberine: treating chronic diseases through multiple targets,” Science China Life Sciences, vol. 58, no. 9, pp. 854–859, 2015.
- E. Barzegar, S. Fouladdel, T. Komeili Movahhed et al., “Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines,” Iranian Journal of Basic Medical Sciences, vol. 18, no. 4, pp. 334–342, 2015.
- P. Jin, C. Zhang, and N. Li, “Berberine exhibits antitumor effects in human ovarian cancer cells,” Anti-Cancer Agents in Medicinal Chemistry, vol. 15, no. 4, pp. 511–516, 2015.
- J. Zhang, H. Cao, B. Zhang et al., “Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling,” Journal of Cellular and Molecular Medicine, vol. 17, no. 11, pp. 1484–1493, 2013.
- X. Xie, X. Chang, L. Chen et al., “Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling,” Molecular and Cellular Endocrinology, vol. 381, no. 1-2, pp. 56–65, 2013.
- T. Lou, Z. Zhang, Z. Xi et al., “Berberine inhibits inflammatory response and ameliorates insulin resistance in hepatocytes,” Inflammation, vol. 34, no. 6, pp. 659–667, 2011.
- H. Cao, S. Song, H. Zhang et al., “Chemopreventive effects of berberine on intestinal tumor development in mice,” BMC Gastroenterology, vol. 13, no. 1, article 163, 2013.
- X. Zhang, R. Goncalves, and D. M. Mosser, “The isolation and characterization of murine macrophages,” in Current Protocols in Immunology, Unit 14.1, 2008.
- A. Siegert, C. Rosenberg, W. D. Schmitt, C. Denkert, and S. Hauptmann, “Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion,” British Journal of Cancer, vol. 86, no. 8, pp. 1310–1315, 2002.
- J. F. Reid, V. Sokolova, E. Zoni et al., “miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation,” Molecular Cancer Research, vol. 10, no. 4, pp. 504–515, 2012.
- X. Liu, Q. Ji, N. Ye et al., “Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway,” PLoS ONE, vol. 10, no. 5, Article ID e0123478, 2015.
- K. M. DiGuilio, C. M. Mercogliano, J. Born et al., “Sieving characteristics of cytokine- and peroxide-induced epithelial barrier leak: inhibition by berberine,” World Journal of Gastrointestinal Pathophysiology, vol. 7, no. 2, pp. 223–234, 2016.
- Y.-H. Li, H.-T. Xiao, D.-D. Hu et al., “Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses,” Pharmacological Research, vol. 110, pp. 227–239, 2016.
- S. Sousa, R. Brion, M. Lintunen et al., “Human breast cancer cells educate macrophages toward the M2 activation status,” Breast Cancer Research, vol. 17, no. 1, article 101, 2015.
- Y.-R. Na, Y.-N. Yoon, D.-I. Son, and S.-H. Seok, “Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model,” PLoS ONE, vol. 8, no. 5, Article ID e63451, 2013.
- K. Bedard and K.-H. Krause, “The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007.
- L. E. Padgett, A. R. Burg, W. Lei, and H. M. Tse, “Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes,” Diabetes, vol. 64, no. 3, pp. 937–946, 2015.
- L. Yi, Q. Liu, M. S. Orandle et al., “ directs murine macrophage cell fate decisions,” The American Journal of Pathology, vol. 180, no. 3, pp. 1049–1058, 2012.
- L. K. Sarna, N. Wu, S.-Y. Hwang, Y. L. Siow, and O. Karmin, “Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages,” Canadian Journal of Physiology and Pharmacology, vol. 88, no. 3, pp. 369–378, 2010.
- F. Cheng, Y. Wang, J. Li et al., “Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans,” International Journal of Cardiology, vol. 167, no. 3, pp. 936–942, 2013.
- S.-E. Cheng, I.-T. Lee, C.-C. Lin, W.-L. Wu, L.-D. Hsiao, and C.-M. Yang, “ATP mediates NADPH oxidase/ROS generation and COX-2/PGE2 expression in A549 cells: role of P2 receptor-dependent STAT3 activation,” PLoS ONE, vol. 8, no. 1, Article ID e54125, 2013.
- H. G. Kim, Y. R. Kim, J. H. Park et al., “Endosulfan induces COX-2 expression via NADPH oxidase and the ROS, MAPK, and Akt pathways,” Archives of Toxicology, vol. 89, no. 11, pp. 2039–2050, 2015.
Copyright © 2016 Meiyu Piao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.